Accessibility Menu
 
Arch Biopartners logo

Arch Biopartners

(OTC) ACHFF

Current Price$0.40
Market Cap$27.04M
Since IPO (2011)-43%
5 Year-60%
1 Year-69%
1 Month-39%

Arch Biopartners Financials at a Glance

Market Cap

$27.04M

Revenue (TTM)

$158.08K

Net Income (TTM)

$2.69M

EPS (TTM)

$-0.03

P/E Ratio

-13.83

Dividend

$0.00

Beta (Volatility)

0.43 (Low)

Price

$0.40

Volume

71,500

Open

$0.48

Previous Close

$0.40

Daily Range

$0.40 - $0.48

52-Week Range

$0.40 - $1.42

ACHFF News

No articles available.

ACHFF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Arch Biopartners

Industry

Life Sciences Tools and Services

CEO

Richard Gabriel Muruve, MBA

Headquarters

Toronto, ON M4T 2M5, CA

ACHFF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

69%

Return on Assets

-108%

Earnings Yield

-7.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$27.04M

Shares Outstanding

66.93M

Volume

71.50K

Short Interest

0.00%

Avg. Volume

30.12K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.50M

EBITDA

$1.29M

Operating Cash Flow

$1.59M

Capital Expenditure

$5.01

Free Cash Flow

$1.59M

Cash & ST Invst.

$2.10K

Total Debt

$2.84M

Arch Biopartners Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$27.04M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$1.56M

-274.5%

EBITDA

$1.48M

-1496.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$2.63M

+5.2%

Accounts Receivable

$6.78K

-98.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$2.63M

-6.9%

Return on Assets

-107.70%

N/A

Return on Invested Capital

69.28%

N/A

Free Cash Flow

$849.25K

+6.0%

Operating Cash Flow

$849.24K

+6.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CVALFCovalon Technologies Ltd.
$1.25+0.81%
ZIVOZIVO Bioscience, Inc.
$9.30+7.14%
OTLCOncotelic Therapeutics, Inc.
$0.04+3.36%
INNMFAmplia Therapeutics Limited
$0.08+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About ACHFF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.